Buspirone
7,545 views
Psych Pharm
- Lithium
- Typical Antipsychotics
- Atypical Antipsychotics
- SSRIs
- SNRIs
- Tricyclic Antidepressants (TCAs)
- Monoamine Oxidase Inhibitors (MAOIs)
- Bupropion
- Mirtazapine
- Trazadone
- Vilazodone
- Vortioxetine
- Buspirone
- Varenicline
Summary
Buspirone is a medication that acts as a partial agonist at serotonin receptors. This drug is a second-line treatment for General Anxiety Disorder. Remember that buspirone has a slow onset of action, roughly taking 2 weeks before clinical symptoms improve.
Key Points
- Buspirone
- Mechanism
- Acts as partial agonist of serotonin 5-HTA1 receptors
- Acts as weak antagonist at dopamine D2 receptors
- Indications
- Treats Generalized Anxiety Disorder (GAD)
- Acts as nonbenzodiazepine anxiolytic
- Has a slow onset of action of 2 weeks
- Not effective in treating acute anxiety attacks
- Used as 2nd line pharmacologic treatment for GAD after SSRIs/SNRIs.
- Treats Generalized Anxiety Disorder (GAD)
- Side Effects
- No risk of tolerance, dependence, or withdrawal
- Contrast vs. benzodiazepines
- Less sedative and hypnotic effects
- Contact vs. benzodiazepines
- Minimal side effects (dizziness)
- No risk of tolerance, dependence, or withdrawal
- Mechanism